Cullinan Therapeutics (CGEM) Stock Chart & Stock Price History $8.48 +0.20 (+2.37%) As of 09:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cullinan Therapeutics Stock Price Performance 5 Day Performance+4.13%1 Month Performance+8.39%3 Month Performance-19.73%6 Month Performance-46.29%Year-To-Date Performance-30.41%1 Year Performance-69.27% Receive CGEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CGEM Stock Chart for Friday, May, 2, 2025 CGEM Chart by TradingView Cullinan Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$8.28$8.52+2.90%$8.59$8.07457,132 shs$502.81 million04/30/2025$7.90$8.28+4.81%$8.41$7.70358,679 shs$488.64 million04/29/2025$7.76$7.90+1.80%$8.04$7.73219,412 shs$462.25 million04/28/2025$8.14$7.76-4.67%$8.31$7.61273,464 shs$454.06 million04/25/2025$8.14$8.14$8.20$7.89250,650 shs$476.30 million04/24/2025$8.38$8.14-2.86%$8.41$7.98218,450 shs$476.30 million04/23/2025$8.37$8.38+0.12%$8.79$8.37377,921 shs$490.34 million04/22/2025$8.10$8.37+3.33%$8.42$7.861.12 million shs$489.75 million04/21/2025$7.89$8.10+2.66%$8.39$7.82342,088 shs$473.96 million04/18/2025$7.89$7.89$7.99$7.38694,937 shs$461.67 million Get the Latest News and Ratings for CGEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$7.61$7.89+3.68%$7.99$7.38694,937 shs$461.67 million04/16/2025$7.80$7.61-2.44%$7.79$7.48413,840 shs$445.28 million04/15/2025$7.74$7.80+0.78%$8.09$7.67573,942 shs$456.40 million04/14/2025$7.71$7.74+0.39%$7.97$7.39410,498 shs$452.89 million04/11/2025$7.58$7.71+1.72%$7.76$7.37679,294 shs$451.14 million04/10/2025$7.79$7.58-2.70%$7.61$7.29478,860 shs$443.53 million04/09/2025$7.32$7.79+6.42%$8.10$6.93450,604 shs$455.82 million04/09/2025$7.32$7.79+6.42%$8.10$6.93450,604 shs$455.82 million04/08/2025$7.25$7.32+0.97%$7.83$7.19804,669 shs$428.32 million04/08/2025$7.25$7.32+0.97%$7.83$7.19804,669 shs$428.32 million04/07/2025$7.41$7.25-2.16%$7.39$6.85768,272 shs$424.22 million04/04/2025$7.49$7.41-1.07%$7.62$7.11600,301 shs$433.58 million04/03/2025$7.82$7.49-4.22%$7.63$7.31573,012 shs$438.26 million04/02/2025$7.50$7.82+4.27%$7.85$7.32395,029 shs$457.57 million04/01/2025$7.57$7.50-0.92%$7.55$7.27613,610 shs$438.85 million Related Companies GLPG Stock Price Chart IDYA Stock Price Chart ARQT Stock Price Chart TVTX Stock Price Chart AGIO Stock Price Chart HRMY Stock Price Chart EWTX Stock Price Chart IRON Stock Price Chart INDV Stock Price Chart KNSA Stock Price Chart Receive CGEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGEM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CGEM Stock Free CGEM Stock Alerts